Page 3 of 19 · 454 questions tagged vendor-vetting.
The lot number on the vial matches the certificate, which at least rules out the easy problem. The empirical answer seems settled. The explanation does not. If the…
Details up front: 99.4% · dulaglutide · QYB. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I have: FGP · Nantong Guangyuan Chemical. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Conditions: WWB · WuXi TIDES. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than a…
I have certificates from two lots and an independent result on one of them. I can find plenty of assertions about this and almost no reasoning, which is usually a…
Details up front: QYB · survodutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
Setup, so nobody has to ask: batch certificate · WXT. This is presented as though it settles something, and I am not convinced it does. I have two documents that…
The specifics, since they change the answer: MKM · Hunan Aslsen Technology. I am trying to choose between two options that are usually discussed as though only one…
For reference: WWB · retatrutide. I have a result I cannot explain, and I would rather diagnose it than guess. I have checked the obvious explanations and eliminated…
The case in front of me: GL Biochem · Hunan Aslsen Technology. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
I am comparing a supplier certificate against an independent result on the same lot. I want to know whether this is a real physical effect or an artefact of how it is…
The specifics, since they change the answer: SWB · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a…
I am comparing three suppliers on documentation rather than on price. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
I am comparing a supplier certificate against an independent result on the same lot. This is one of those things that everyone repeats and nobody derives. This…
Concretely: FGP · Shanghai Sigma-Audley. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
Conditions: 99.1% · oral semaglutide · WXT. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan I write…
The method section is present, which is unusual enough that I want to make use of it. This is one of those things that everyone repeats and nobody derives. This…
Details up front: list of related substances · QYB. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Stated plainly: 97.1% · cagrilintide · TFC. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not tight, and my…
For reference: SSA · survodutide. Something has gone wrong and I would like to know how badly before I decide what to do. Nothing else in the setup changed, which is…
The lot number on the vial matches the certificate, which at least rules out the easy problem. This is a procedural question rather than a theoretical one, and I…
The case in front of me: 98.4% · liraglutide · BCH. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
The lane and the lead time matter as much as the material for what I am doing. I want a method I can write down and repeat, not a rule of thumb. I would rather…
The specifics, since they change the answer: GL Biochem · survodutide. An unexpected observation, and I would like a differential rather than reassurance. The…